Comparison of polymerase chain reaction methods, in situ hybridization, and enzyme immunoassay for detection of Chlamydia pneumoniae in atherosclerotic carotid plaques

Diagnostic Microbiology and Infectious Disease

Volumn 61, Issue 2, 2008, Pages 156-164

  Lajunen, Taina ^a,b   Vikatmaa, Pirkka ^c   Ikonen, Tuija ^c,d   Lepäntalo, Mauri ^c   Lounatmaa, Kari ^e   Sormunen, Raija ^b   Rantala, Aino ^a,b   Leinonen, Maija ^a   Saikku, Pekka ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e Oy Lounatmaa Ltd   (Finland)

Author keywords

Atherosclerotic plaques; Chlamydia pneumoniae; cLPS; EIA; In situ hybridization; PCR

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; DNA;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIUM DETECTION; CAROTID ARTERY DISEASE; CHLAMYDOPHILA PNEUMONIAE; DNA DETERMINATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE HOMOGENATE;

AGED; CAROTID STENOSIS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 43549087599     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.01.006     Document Type: Article

References (45)

1. Alakärppä H., Surcel H.M., Laitinen K., Juvonen T., Saikku P., and Laurila A. Detection of Chlamydia pneumoniae by colorimetric in situ hybridization. APMIS 107 (1999) 451-454
2. Ameriso S.F., Fridman E.A., Leiguarda R.C., and Sevlever G.E. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32 (2001) 385-391
3. Apfalter P. Chlamydia pneumoniae, stroke, and serological associations: anything learned from the atherosclerosis-cardiovascular literature or do we have to start over again?. Stroke 37 (2006) 756-758
4. Apfalter P., Loidl M., Nadrchal R., Makristathis A., Rotter M., Bergmann M., Polterauer P., and Hirschl A.M. Isolation and continuous growth of Chlamydia pneumoniae from arterectomy specimens. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 305-308
5. Apfalter P., Blasi F., Boman J., Gaydos C.A., Kundi M., Maass M., Makristathis A., Meijer A., Nadrchal R., Persson K., Rotter M.L., Tong C.Y., Stanek G., and Hirschl A.M. Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J. Clin. Microbiol. 39 (2001) 519-524
6. Apfalter P., Assadian O., Blasi F., Boman J., Gaydos C.A., Kundi M., Makristathis A., Nehr M., Rotter M.L., and Hirschl A.M. Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols. J. Clin. Microbiol. 40 (2002) 4428-4434
7. Apfalter P., Barousch W., Nehr M., Makristathis A., Willinger B., Rotter M., and Hirschl A.M. Comparison of a new quantitative ompA-based real-time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays. J. Clin. Microbiol. 41 (2003) 592-600
8. Apfalter P., Barousch W., Nehr M., Willinger B., Rotter M., and Hirschl A.M. No evidence of involvement of Chlamydia pneumoniae in severe cerebrovascular atherosclerosis by means of quantitative real-time polymerase chain reaction. Stroke 35 (2004) 2024-2028
9. Bellete B., Flori P., Hafid J., Raberin H., and Tran Manh Sung R. Influence of the quantity of nonspecific DNA and repeated freezing and thawing of samples on the quantification of DNA by the Light Cycler. J. Microbiol. Methods 55 (2003) 213-219
10. Campbell L.A., Perez Melgosa M., Hamilton D.J., Kuo C.C., and Grayston J.T. Detection of Chlamydia pneumoniae by polymerase chain reaction. J. Clin. Microbiol. 30 (1992) 434-439
11. Ciervo A., Petrucca A., and Cassone A. Identification and quantification of Chlamydia pneumoniae in human atherosclerotic plaques by LightCycler real-time-PCR. Mol. Cell. Probes 17 (2003) 107-111
12. Cirino F., Webley W.C., West C., Croteau N.L., Andrzejewski Jr. C., and Stuart E.S. Detection of chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques. BMC Infect. Dis. 6 (2006) 23
13. Cochrane M., Pospischil A., Walker P., Gibbs H., and Timms P. Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures. J. Clin. Microbiol. 41 (2003) 1454-1457
14. TM Chlamydia, K6002 (2003), Dako Ltd, Cambridgeshire, UK
15. Gaydos C.A. Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J. Infect. Dis. 181 Suppl 3 (2000) S473-S478
16. Hoymans V.Y., Bosmans J.M., Ursi D., Martinet W., Wuyts F.L., Van Marck E., Altwegg M., Vrints C.J., and Ieven M.M. Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents. J. Clin. Microbiol. 42 (2004) 3219-3224
17. Ieven M.M., and Hoymans V.Y. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J. Clin. Microbiol. 43 (2005) 19-24
18. Jackson L.A., Campbell L.A., Kuo C.C., Rodriguez D.I., Lee A., and Grayston J.T. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J. Infect. Dis. 176 (1997) 292-295
19. Kaklikkaya I., Kaklikkaya N., Buruk K., Pulathan Z., Koramaz I., Aydin F., Tosun I., Osman Kilic A., and Özcan F. Investigation of Chlamydia pneumoniae DNA, chlamydial lipopolysaccharide antigens, and Helicobacter pylori DNA in atherosclerotic plaques of patients with aortoiliac occlusive disease. Cardiovasc. Pathol. 15 (2006) 105-109
20. Kalayoglu M.V., and Byrne G.I. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect. Immun. 66 (1998) 5067-5072
21. Kalayoglu M.V., and Byrne G.I. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J. Infect. Dis. 177 (1998) 725-729
22. Kalayoglu M.V., Hoerneman B., LaVerda D., Morrison S.G., Morrison R.P., and Byrne G.I. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J. Infect. Dis. 180 (1999) 780-790
23. Kowalski M., Rees W., Konturek P.C., Grove R., Scheffold T., Meixner H., Brunec M., Franz N., Konturek J.W., Pieniazek P., Hahn E.G., Konturek S.J., Thale J., and Warnecke H. Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig. Liver Dis. 34 (2002) 398-402
24. Kozarov E., Sweier D., Shelburne C., Progulske-Fox A., and Lopatin D. Detection of bacterial DNA in atheromatous plaques by quantitative PCR. Microbes Infect. 8 (2006) 687-693
25. Kuo C.C., Jackson L.A., Campbell L.A., and Grayston J.T. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8 (1995) 451-461
26. Leinonen M., and Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect. Dis. 2 (2002) 11-17
27. Maass M., Bartels C., Engel P.M., Mamat U., and Sievers H.H. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J. Am. Coll. Cardiol. 31 (1998) 827-832
28. Maass M., Jahn J., Gieffers J., Dalhoff K., Katus H.A., and Solbach W. Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction. J. Infect. Dis. 181 Suppl 3 (2000) S449-S451
29. Meijer A., van Der Vliet J.A., Roholl P.J., Gielis-Proper S.K., de Vries A., and Ossewaarde J.M. Chlamydia pneumoniae in abdominal aortic aneurysms: abundance of membrane components in the absence of heat shock protein 60 and DNA. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2680-2686
30. Meijer A., Roholl P.J., Gielis-Proper S.K., and Ossewaarde J.M. Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions. J. Clin. Pathol. 53 (2000) 911-916
31. Mosorin M., Surcel H.M., Laurila A., Lehtinen M., Karttunen R., Juvonen J., Paavonen J., Morrison R.P., Saikku P., and Juvonen T. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1061-1067
32. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl. J. Med. 325 (1991) 445-453
33. Ramirez J.A. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann. Intern. Med. 125 (1996) 979-982
34. Reischl U., Lehn N., Simnacher U., Marre R., and Essig A. Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR. Eur. J. Clin. Microbiol. Infect. Dis. 22 (2003) 54-57
35. Royo J., Gimez E., and Hueros G. CMP-KDO synthetase: a plant gene borrowed from gram-negative eubacteria. Trends Genet. 16 (2000) 432-433
36. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Mäkela P.H., Huttunen J.K., and Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2 (1988) 983-986
37. Saikku P., Leinonen M., Tenkanen L., Linnanmaki E., Ekman M.R., Manninen V., Mänttari M., Frick M.H., and Huttunen J.K. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Intern. Med. 116 (1992) 273-278
38. Sako T., Takahashi T., Takehana K., Uchida E., Nakade T., Umemura T., and Taniyama H. Chlamydial infection in canine atherosclerotic lesions. Atherosclerosis 162 (2002) 253-259
39. Sessa R., Di Pietro M., Schiavoni G., Santino I., Benedetti-Valentini F., Perna R., Romano S., and del Piano M. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease. J. Vasc. Surg. 37 (2003) 1027-1031
40. Shor A., and Phillips J.I. Histological and ultrastructural findings suggesting an initiating role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis. Cardiovasc. J. S. Afr. 11 (2000) 16-23
41. Slot J.W., and Geuze H.J. A new method of preparing gold probes for multiple-labeling cytochemistry. Eur. J. Cell. Biol. 38 (1985) 87-93
42. Smieja M., Mahony J.B., Goldsmith C.H., Chong S., Petrich A., and Chernesky M. Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens. J. Clin. Microbiol. 39 (2001) 1796-1801
43. Takahashi K., Takeya M., and Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med. Electron. Microsc. 35 (2002) 179-203
44. Tiirola T., Jaakkola A., Bloigu A., Paldanius M., Sinisalo J., Nieminen M.S., Silvennoinen-Kassinen S., Saikku P., Jauhiainen M., and Leinonen M. Novel enzyme immunoassay utilizing lipopolysaccharide-binding protein as a capture molecule for the measurement of chlamydial lipopolysaccharide in serum. Diagn. Microbiol. Infect. Dis. 54 (2006) 7-12
45. Törmäkangas L., Erkkilä L., Korhonen T., Tiirola T., Bloigu A., Saikku P., and Leinonen M. Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice. Infect. Immun. 73 (2005) 6458-6466